Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytochrome 2C19 polymorphism and response to adjunctive cilostazol versus high maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention.
Hwang SJ, Jeong YH, Kim IS, Park KS, Kang MK, Koh JS, Park JR, Park Y, Koh EH, Kwak CH, Hwang JY, Kim S. Hwang SJ, et al. Among authors: park y, park ks, park jr. Circ Cardiovasc Interv. 2010 Oct;3(5):450-9. doi: 10.1161/CIRCINTERVENTIONS.110.949859. Epub 2010 Sep 7. Circ Cardiovasc Interv. 2010. PMID: 20823393 Clinical Trial.
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Kim IS, Jeong YH, Park Y, Park KS, Yun SE, Park JR, Hwang SJ, Koh EH, Kwak CH, Hwang JY, Kim S. Kim IS, et al. Among authors: park y, park ks, park jr. JACC Cardiovasc Interv. 2011 Apr;4(4):381-91. doi: 10.1016/j.jcin.2010.12.010. JACC Cardiovasc Interv. 2011. PMID: 21511217 Free article. Clinical Trial.
Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
Kim IS, Jeong YH, Park Y, Yoon SE, Kwon TJ, Park JR, Hwang SJ, Koh EH, Kwak CH, Hwang JY, Kim S. Kim IS, et al. Among authors: park y, park jr. Br J Clin Pharmacol. 2012 Apr;73(4):629-40. doi: 10.1111/j.1365-2125.2011.04131.x. Br J Clin Pharmacol. 2012. PMID: 22007612 Free PMC article.
Delayed ventricular septal rupture following blunt chest trauma.
Kim NY, Kwon TJ, Park JR, Choi HC, Cheon YH, Kang MK, Hwang SJ, Park Y, Jeong YH, Kwak CH, Hwang JY. Kim NY, et al. Among authors: park y, park jr. Korean Circ J. 2011 Oct;41(10):625-8. doi: 10.4070/kcj.2011.41.10.625. Epub 2011 Oct 31. Korean Circ J. 2011. PMID: 22125565 Free PMC article.
Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
Park Y, Jeong YH, Tantry US, Ahn JH, Kwon TJ, Park JR, Hwang SJ, Gho EH, Bliden KP, Kwak CH, Hwang JY, Kim S, Gurbel PA. Park Y, et al. Among authors: park jr. Eur Heart J. 2012 Sep;33(17):2151-62. doi: 10.1093/eurheartj/ehs083. Epub 2012 Apr 16. Eur Heart J. 2012. PMID: 22507978 Clinical Trial.
Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention.
Jeong YH, Tantry US, Park Y, Kwon TJ, Park JR, Hwang SJ, Bliden KP, Koh EH, Kwak CH, Hwang JY, Kim S, Gurbel PA. Jeong YH, et al. Among authors: park y, park jr. Diabetes Care. 2012 Nov;35(11):2194-7. doi: 10.2337/dc11-2351. Epub 2012 Jul 26. Diabetes Care. 2012. PMID: 22837373 Free PMC article.
460 results